64x Bio was founded by Lexi Rovner in 2017.

Who are 64x Bio's investors?

64x Bio's investors include Fifty Years, Future Ventures, G Ventures, Lifeforce Capital, Raptor Group, Y Combinator, Alix Ventures, BoxGroup and 7 more.

How much funding has 64x Bio raised?

64x Bio has disclosed $55M raised across 1 round.

Where is 64x Bio headquartered?

64x Bio is headquartered in San Francisco, US.

64x Bio

YC S18

San Francisco, US · Founded 2017 · 25 employees · 15 known investors

Find your way into 64x Bio

Paths you didn't know you had: your email and LinkedIn already hold routes to the 64x Bio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

64x develops infrastructure and manufacturing systems for next-generation medicines, focusing on genetic engineering, cell line development, and computational biology to enable scalability of advanced therapies.

Also known as 64-X, Inc. · 64-x · 64-X · 64-X, 64-x

AI & Machine Learning Biotech Deep Tech Healthtech Medical Devices Gene Therapy Machine LearningUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S18)

64x Bio was founded in 2017 by Lexi Rovner.

Lexi Rovner CEOLexi Rovner holds a PhD from Yale University and completed postdoctoral research in George Church's laboratory at Harvard Medical School. She is the CEO and co-founder of 64x Bio, a company that emerged from Harvard Medical School and the Wyss Institute.

Alexis RovnerFounder

Ryan Gallagher

Emily HawkinsHead of Talentformer

Investors · 15

Fifty Yearslisted by Fifty YearsSan Francisco · $250K – $2M

How we know: Fifty Years's portfolio page · biospace.com · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Future Ventureslisted by Future VenturesLos Altos · $1M – $10M

How we know: Future Ventures's portfolio page · biospace.com · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

G Ventureslisted by G Ventures

How we know: Y Combinator's founder network · Not right? Tell us

Lifeforce Capitallisted by Lifeforce CapitalChevy Chase · $500K – $5M

How we know: Lifeforce Capital's portfolio page · a partner's Signal profile · biospace.com · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Raptor Grouplisted by Raptor GroupMiami Beachvia James J. Pallotta · inferred

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Alix VenturesreportedSan Francisco · $100K – $500K

How we know: biospace.com · Y Combinator's founder network · Not right? Tell us

BoxGroupreportedNew York · $250K – $1M

How we know: biospace.com · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

First Round CapitalreportedSan Francisco · $100K – $20M

How we know: biospace.com · Y Combinator's founder network · Not right? Tell us

FrialereportedNashville · $100K – $600K

How we know: Y Combinator's founder network · Not right? Tell us

Liquid VenturesreportedSan Francisco · $250K – $5M

How we know: Y Combinator's founder network · open dataset · 5k.vc investor directory · Not right? Tell us

Northpond VenturesreportedBethesda · $100K – $5M

How we know: biospace.com · Y Combinator's founder network · Not right? Tell us

Refactor CapitalreportedBurlingame · $1M – $2M

How we know: biospace.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

SV AngelreportedSan Francisco · $150K – $20M

How we know: biospace.com · Y Combinator's founder network · Not right? Tell us

Venture Investment AssociatesreportedPeapack

How we know: Y Combinator's founder network · Not right? Tell us

Funding

SEC filings, press & company announcements

$55M disclosed across 1 round · 2022

$55MSeries AJan 2022 · 2 sources
Lifeforce Capital (lead), Alix Ventures, BoxGroup, Fifty Years, First Round Capital, Future Ventures, Northpond Ventures, Refactor Capital, SV Angel
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 6

Perception BiosystemsPerception Biosystems develops automated manufacturing systems for gene therapy production, aiming to reduce the time and cost of producing therapies for rare disease clinical trials.

Nuntius TherapeuticsNuntius develops programmable nanocarriers for drug delivery that can target tissues beyond the liver and utilize machine learning to optimize carrier performance. The company serves pharmaceutical and biotech organizations developing targeted therapeutics.

FinalDoseFinalDose develops a programmable DNA-targeting molecule designed to recognize and destroy cells carrying specific genetic sequences, with initial applications in oncology across cancer types.

WhiteLab GenomicsWhiteLab Genomics uses AI and computational methods to analyze biological data and accelerate genomic drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to reduce timelines and de-risk the development of genomic medicines.

Xenetic BiosciencesXenetic Biosciences is a biopharmaceutical company developing immuno-oncology technologies for hard-to-treat cancers. Its DNase platform targets neutrophil extracellular traps (NETs) to improve existing treatments, with a systemic DNase program being advanced into the clinic as an adjunctive therapy for pancreatic carcinoma and other solid tumors.

Bio X CellSupplier of 400+ research-use monoclonal antibodies serving academic, government, and commercial research customers worldwide.

Companies working in the same space as 64x Bio.

Legal entities · 1

corporate structure

64-X, Inc.

In the news

64x Bio Raises $55 Million Series A Financing to Advance Cell Line Engineering Platform for Gene Therapy Manufacturing - BioSpacebiospace.com · Jan 2022

Frequently asked questions

What does 64x Bio do?: 64x develops infrastructure and manufacturing systems for next-generation medicines, focusing on genetic engineering, cell line development, and computational biology to enable scalability of advanced therapies.
Who founded 64x Bio?: 64x Bio was founded by Lexi Rovner in 2017.
Who are 64x Bio's investors?: 64x Bio's investors include Fifty Years, Future Ventures, G Ventures, Lifeforce Capital, Raptor Group, Y Combinator, Alix Ventures, BoxGroup and 7 more.
How much funding has 64x Bio raised?: 64x Bio has disclosed $55M raised across 1 round.
Where is 64x Bio headquartered?: 64x Bio is headquartered in San Francisco, US.